Bio

Mark is a Partner and Head of Development Capital at Downing. With over 18 years of private equity experience across origination, transaction and portfolio management, he has managed over £1 billion of equity and debt capital. He has extensive company board experience and has worked across a range of industry sectors including Healthcare, Hospitality and Leisure, Retail, Business Services, Specialty Manufacturing & Financial Services. He has experience of investing in private and quoted companies with knowledge of operating businesses and real estate investment. Since joining Downing in June 2014, Mark has been spearheading the expansion of Downing's healthcare activities and the wider development capital team. Consequently, Downing has been recognised as Private Equity Investor of the Year at the HealthInvestor Awards 2020 and in 2021, Mark was recognised in HealthInvestor’s Power Fifty as one of the industry’s 50 most effective, inspiring and influential leaders across the health and social care market. Mark joined Downing from the UK mid-market private equity firm, Caird Capital LLP. Prior to that he performed principal investment and leveraged finance roles at Bank of Scotland.